Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery

SARS-CoV-2 vaccination has been launched worldwide to build effective population-level immunity to curb the spread of this virus. The effectiveness and duration of protective immunity is a critical factor for public health. Here, we report the kinetics of the SARS-CoV-2 specific immune response in 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Chengqian, Shi, Jingrong, Fan, Qinghong, Wang, Yaping, Huang, Huang, Chen, Fengjuan, Tang, Guofang, Li, Youxia, Li, Pingchao, Li, Jiaojiao, Cui, Jianping, Guo, Liliangzi, Chen, Sisi, Jiang, Mengling, Feng, Liqiang, Chen, Ling, Lei, Chunliang, Ke, Changwen, Deng, Xilong, Hu, Fengyu, Tang, Xiaoping, Li, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370972/
https://www.ncbi.nlm.nih.gov/pubmed/34404803
http://dx.doi.org/10.1038/s41467-021-25312-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370972/
https://www.ncbi.nlm.nih.gov/pubmed/34404803
http://dx.doi.org/10.1038/s41467-021-25312-0

Ejemplares similares